Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Guangzhou Improve Medical Instruments to IPO on ChiNext

publication date: Dec 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guangzhou Improve Medical Instruments Co., Ltd, an in-vitro diagnostics company, is scheduled to make its IPO on Shenzhen’s ChiNext exchange. The company has established a price of 25 RMB ($3.67) per share for the offering’s 18.6 million shares, making the IPO worth $68 million. Its major product is evacuated blood collection systems. Improve Medical Instruments is the only life science company among the eight companies involved in ChiNext’s second round. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...